With the Tom Baker Cancer Centre located in Calgary, the city is already a leader in research and the treatment of cancer. The new Calgary Cancer Centre, set to open in 2023, will increase capacity and add to Calgary’s already leading role in cancer services.
The new Calgary Cancer Centre (CCC) will be a world-class health care facility and academic centre for the provision of cancer services in Southern Alberta. The CCC will be constructed at the Foothills Medical Centre (FMC) to integrate cancer care with current key programs and services at the FMC site.
The CCC will increase cancer care capacity in southern Alberta by consolidating and expanding existing services to support integrated and comprehensive cancer care. The CCC is planned to meet clinical, academic and research needs as a full, comprehensive cancer facility. The CCC will support and deliver an interdisciplinary and integrated care philosophy that accommodates research, education and patient- and family-centred care, and improves patient outcomes.
Historically, Alberta’s economic engine has been its natural resources. Another major Alberta resource that is less well known is health data. Much like natural resources, data needs to be mined, refined, and put into a form to be used practically in day-to-day situations. While the fuel stores in Alberta are finite, the abundance of health data and application of that data for payers, health policy decisions and evidence generation are limitless.
This electronic medical record system for cancer patients in Alberta, managed by Cancer Control Alberta, is the system that houses chemotherapy, progress notes, referral and demographic information as well as pathology data and diagnostic imaging data.
The ACR contains information on patients diagnosed or treated in Alberta. Data collected includes demographic, initial treatment, mortality and tumour information. The information based on initial diagnosis and treatment within one year after diagnosis. Treatment data focuses on the occurrence of surgery, chemotherapy or radiotherapy.
The ACRB collects biological materials from participants as well as cancer-related clinical data. There is data on approximately 26,000 patients.
This initiative at the University of Calgary aims to develop strategies and methods for non-invasive earlier detection of cancer, discover better ways to predict the behaviour of individual cancers and accelerate the development of new commercially viable cancer detection tests and technologies.
This program is designed to monitor current treatment responses and to develop new strategies to identify tailored therapies for cancer patients.